PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
Here, we report development of AAV-carried therapeutic gene construct consisting of cell-specific promoter driven Multi-Characteristic Opsin (MCO-II) to target inhibitory cells of ACC. MCO-II is highly sensitive to light and can be activated at low intensity, thus requiring a very low power budget. This along with red-light sensitiveness of MCO allows deep penetration with a minimally invasive implant. We developed a wireless Bluetooth Optogenetic Pain Modulator device for control of the dose of optogenetic stimulation. We demonstrated that red light stimulation of inhibitory neurons in ACC expressing MCO-II leads to significant reduction in pain response in fully awake animals.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Darryl Narcisse, Robert Benkowski, Arman Fijany, Samarendra K. Mohanty, "Pain modulation by multi-characteristic opsin sensitization of inhibitory network of brain," Proc. SPIE 11629, Optical Techniques in Neurosurgery, Neurophotonics, and Optogenetics, 1162914 (5 March 2021); https://doi.org/10.1117/12.2586107